Equities
Basic MaterialsChemicals
  • Price (GBX)4,902.00
  • Today's Change49.00 / 1.01%
  • Shares traded405.64k
  • 1 Year change-23.17%
  • Beta0.7765
Data delayed at least 20 minutes, as of Mar 28 2024 18:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Croda International PLC is a life sciences and consumer care company. Its segments include Consumer Care, Life Sciences and Industrial Specialties. The Consumer Care segment is focused on high-value niches in the markets of skin care, hair care, solar protection, fabric and surface care, and fragrances. The Consumer Care comprises four businesses: beauty care, beauty actives, home care and fragrances and flavors. Its Life Sciences segment is engaged in providing quality health care solutions, protecting crops and enhancing seeds. The Company is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein and nucleic acid delivery platforms. It is engaged in offering ingredients that improve the performance and delivery of crop formulations. It offers seed coating systems to improve germination, stimulate healthy development of seeds and crop yield. It is also focused on biotechnology-derived active ingredients for beauty care and pharmaceuticals.

  • Revenue in GBP (TTM)1.69bn
  • Net income in GBP171.00m
  • Incorporated1925
  • Employees5.85k
  • Location
    Croda International PlcCowick HallGOOLE DN14 9AAUnited KingdomGBR
  • Phone+44 140 586 0551
  • Fax+44 140 586 1767
  • Websitehttps://www.croda.com/en-gb
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Siegfried Holding AG1.12bn98.45m3.65bn3.93k35.054.6621.423.2726.2826.28298.23197.490.69582.273.14323,288.606.176.517.677.9825.2023.248.869.061.397.930.346815.263.419.87-28.1618.3417.956.72
Laboratorios Farmaceuticos ROVI SA708.93m145.58m3.73bn2.11k25.257.7722.845.273.203.2015.5810.410.98831.045.13392,946.0020.2918.9028.8825.5859.3559.8220.5320.130.8575--0.107533.601.4422.30-14.6956.9315.8469.11
Richter Gedeon Vegyeszeti Gyar Nyrt1.75bn344.67m3.74bn12.17k10.791.508.162.14857.81857.794,349.056,173.080.59311.714.08--11.8311.6413.3913.2864.7558.1819.9518.933.127.490.015939.700.299312.57-6.0535.0615.5933.38
Orion Oyj1.02bn185.29m4.17bn3.63k22.345.4518.494.101.551.558.496.340.80881.575.56327,588.1014.7219.4718.0324.1655.3059.3818.2020.711.7594.790.183591.83-11.264.01-37.971.8911.821.55
Hikma Pharmaceuticals Plc2.28bn150.53m4.26bn8.97k28.322.4411.911.870.67740.677410.247.880.62841.763.67254,017.604.208.195.7211.3048.9450.296.6813.770.90297.680.350336.7114.226.731.06-7.597.974.54
DiaSorin SpA-85.46bn-85.46bn4.28bn3.28k--------------------------13.14--14.79--67.40--23.33------23.899.9816.38-22.5311.4921.765.29
Grifols SA5.63bn50.69m4.38bn23.74k92.510.97178.240.77830.09010.09019.808.580.30681.239.86277,627.000.84082.391.063.0437.8440.262.747.541.291.560.5593--8.718.00-71.52-36.98-0.8127--
Zealand Pharma A/S39.28m-80.64m4.89bn253.00--24.98--124.49-12.57-12.576.0127.280.19484.16289.881,354,889.00-39.99-42.74-46.30-50.2487.3996.13-205.30-464.666.23--0.0696--229.6555.2727.12--42.53--
BACHEM HOLDING AG507.20m98.27m5.69bn2.01k57.634.9141.2611.221.501.507.7317.610.37651.233.33287,794.607.298.858.1710.2830.6531.6319.3819.743.0429.800.000355.378.5715.3711.1019.1250.887.78
Croda International Plc1.69bn171.00m6.84bn5.85k40.082.9122.954.041.221.2212.1216.850.47132.404.39289,559.104.7910.805.4212.5143.0846.4110.1618.641.7717.070.230743.44-18.904.09-73.66-6.4212.784.11
Swedish Orphan Biovitrum AB (publ)1.64bn178.37m7.01bn1.79k36.112.6816.884.287.407.4068.6599.680.34971.384.25--3.815.935.207.6077.5877.4110.8816.610.46074.040.37690.0017.7419.34-8.68-0.072953.61--
Qiagen NV1.56bn270.41m7.54bn5.97k28.122.4917.414.841.411.418.1415.950.31691.935.38305,333.005.505.416.606.5362.7764.6517.3716.351.62--0.2839---8.235.53-19.3512.381.55--
Ipsen SA2.83bn527.40m7.90bn5.07k14.922.3813.022.807.397.7239.6646.290.5541.995.23--10.489.7113.9313.3382.7282.7618.9116.020.98930.430.110619.874.757.084.039.75-8.653.71
Recordati Industria Chmc Frmctc SpA1.74bn320.81m9.16bn4.37k28.216.1120.585.271.821.829.848.390.4951.574.99465,081.009.1412.8211.5916.3868.7871.0518.4722.480.859911.850.512861.8317.297.55-19.081.5845.876.23
Eurofins Scientific SE5.57bn441.42m9.74bn61.80k22.632.2310.071.752.611.3032.9226.440.621336.204.79105,417.605.417.496.709.3620.9323.788.7111.231.388.430.433219.28-2.9411.49-21.5310.918.5811.66
Data as of Mar 28 2024. Currency figures normalised to Croda International Plc's reporting currency: UK Pound GBX

Institutional shareholders

35.17%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 08 Feb 20249.80m7.02%
Massachusetts Financial Services Co.as of 22 Jun 20237.01m5.02%
Mawer Investment Management Ltd.as of 31 Dec 20216.44m4.61%
The Vanguard Group, Inc.as of 02 Dec 20235.26m3.77%
RBC Global Asset Management (UK) Ltd.as of 31 Dec 20225.01m3.59%
MFS International (UK) Ltd.as of 02 Dec 20233.61m2.59%
BlackRock Fund Advisorsas of 02 Dec 20233.46m2.48%
Royal London Asset Management Ltd.as of 02 Dec 20233.29m2.36%
Impax Asset Management Ltd.as of 02 Dec 20232.94m2.11%
Legal & General Investment Management Ltd.as of 02 Dec 20232.28m1.63%
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.